| Report ID | 280886 |
| Drug Identification Number | 02527804 |
| Brand name | PAXLOVID |
| Common or Proper name | PAXLOVID (FOR MODERATE RENAL IMPAIRMENT) |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | NIRMATRELVIR RITONAVIR |
| Strength(s) | 150MG 100MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | Blisters |
| ATC code | J05AE |
| ATC description | |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2026-03-16 |
| Actual discontinuation date | 2026-03-16 |
| Remaining supply date | |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Last batch on the market is MG9028, expriy Oct/31/2026 |
| Company comments | Please note that Paxlovid DIN 02524031 remains fully available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected] |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-03-20 | French | Compare |
| v1 | 2026-03-20 | English | Compare |
Showing 1 to 2 of 2